Stephen T Armenti, MD PhD
Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
View 2 additional locations
Schedule onlineCall 215-662-8100
Headshot of Stephen T Armenti, MD PhD
Penn Medicine Provider

About me

  • Medical Director of Scheie at Penn Presbyterian
  • Assistant Professor of Clinical Ophthalmology

Education and training

  • Medical School: New York University School of Medicine
  • Residency: Northwell Health
  • Residency: University of Michigan
  • Residency: University of Michigan Health
  • Fellowship: University of Michigan

What my patients think about me

Average Rating

2144 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
March 2026
great service
Anonymous
March 2026
he's the best
Anonymous
March 2026
super professional, calming, positive
Anonymous
March 2026
spoke in slow and clear tone. wanted to know my concern and address it positively.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Armenti is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Gannamaneni K, Shapiro JN, Levine H, Reddy K, Armenti ST, Mian SI. Management of Post-Operative Inflammation After Cataract Surgery with Intracanalicular Dexamethasone Implant and Topical Ketorolac , Clin Ophthalmol: 2026

Gannamaneni K, Reddy K, Shapiro JN, Levine H, Verkade AJ, Armenti ST, Hood CT, Mian SI. Subconjunctival Triamcinolone Acetonide Injection Compared with Dexamethasone Ophthalmic Insert for Inflammation Prophylaxis After Cataract Surgery: A Comparative Clinical Study. , Clin Ophthalmol: 2026

Huang AY, Rao N, Sulewski ME, Armenti ST. Dropless cataract surgery: comparing sub-Tenon's and topical steroids for postoperative inflammation prophylaxis. , Eye (London): 2026

Alan Y Huang, Nitya Rao, and Stephen T Armenti Dropless Cataract Surgery: A Review of the Literature , Int Ophthalmol Clin: 2025

Vogt EL, Niziol LM, Yang Z, Wang Y, Pawar M, Dmitriev P, Gupta AS, Armenti ST, Hood CT, Shtein RM, Kipley MM, Lee MC, Sumithra SR, Thulukanam M, Kochar P, Selvaraj S, Redd TK, Prajna NV, Farsiu S, Woodward MA. Association of Deep Learning Imaging Algorithm Measures of Microbial Keratitis With Vision Outcomes. , Cornea: 2025

Shapiro JN, Armenti ST, Levine H, Hood CT, Mian SI. Dexamethasone Intracanalicular Insert versus Standard Topical Steroids for the Prophylaxis of Inflammation after Cataract Surgery , Am J Ophthalmol: 2024

Taylor J Linaburg, Qi N Cui, Stephen Armenti Evaluation and Management of post-operative complications following cataract extraction and intraocular lens placement , Adv Ophthalmol Optom: 2024

Jennifer M Enright, Boonkit Purt, Brent Bruck, Parth Shah, Emily Eton, Sina Rezaei, Stephen Armenti, Kishan G Patel, James Liu, Angela Verkade, Abdualrahman Hamad, Thomas J Wubben, Arsham Sheybani, David Crandall, Bradford L Tannen, Grant M Comer, Shahzad Mian, and Nambi Nallasamy Severe Spontaneous Tilt of Scleral-Fixated Intraocular Lenses , Am J Ophthalmology: 2024

Angela S Gupta, Michael E Sulewski, and Stephen T Armenti Performance of ChatGPT in cataract surgery counseling , J Cataract Refract Surg: 2024

Jasmine Y. Serpen, William Presley, Adelyn Beil, Stephen T. Armenti, Kayla Johnson, Shahzad I. Mian, Jeffrey W. Innis and Lev Prasov A Novel 13q12 Microdeletion Associated with Familial Syndromic Corneal Opacification , Genes, 14(5): 2023